| Risperdal Consta (risperidone depot formulation) / J&J |
2004-004482-15: Hirnaktivierung während Gedächtnisaufgaben bei Patienten mit Schizophrenie unter Behandlung von Ziprasidon oder Risperidon. Eine FMRT-Untersuchung. |
|
|
| Ongoing | 4 | 28 | Europe | Ziprasidon (Zeldox), Risperidon (Risperdal) Tablette, Risperidon (Risperdal) Lösung, Risperidon (Risperdal) Quicklet, Risperidon (Risperdal) Consta, Zeldox, Risperidon (Risperdal), Zeldox, Risperidon (Risperdal) | Universitätsklinikum Aachen, Klinik f. Psychiatrie und Psychotherapie | Patienten mit DSM-IVTR diagnostizierter Schizophrenie | | | | |
| Ongoing | 3 | 250 | RoW | LY03004, RISPERDAL® CONSTA®, TEST, REFERENCE, Powder and solvent for prolonged-release suspension for injection, EU Risperdal® Consta® | Nanjing Luye Pharmaceutical Co., Ltd., Nanjing Luye Pharmaceutical Co., Ltd., Luye Pharma Group, Ltd. | schizophrenia, schizophrenia, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
ChiCTR1800018599: Bioequivalence study of Risperidone in patients with schizophrenia or bipolar I disorder |
|
|
| Not yet recruiting | N/A | 24 | | Risperidone Long-acting intramuscular injection of Qilu Pharmaceuticals Co. Ltd. ;RISPERDAL CONSTA? (Risperidone) LONG-ACTING INJECTION of Janssen Pharmaceuticals | Qilu Pharmaceutical Co., Ltd/CBCC Global Research LLP India; Qilu Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co.,Ltd | Schizophrenia or Bipolar I Disorder | | | | |
| Recruiting | N/A | 50 | | | Janssen-Cilag, Janssen-Cialg Research Fund | Schizophrenia | | | | |
ACTRN12609000317291: A Randomised Control Trial of people with psychosis taking Risperdal Consta compared to people with psychosis taking Risperdal Consta and receiving Collaborative Therapy (a psychoeducational program) in a naturalistic setting |
|
|
| Recruiting | N/A | 200 | | | Prof. David Castle, Janssen-Cilag | Psychosis | | | | |
